Molecular Imaging Market: By Techniques & By Geography - Forecast 2016-2021

  • ID: 3974027
  • Report
  • 141 pages
  • IndustryARC
1 of 3
Molecular imaging market has grown manifold during the course of time, primarily due to increasing demand for detection and monitoring of disease such as cancer and other rare genetic disorders. Globally, aging population, the adoption and advancement in technologies such as PET/CT, non-ionizing imaging techniques and growing demand for efficient and accurate imaging system are the prime growth drivers of molecular Imaging market. In addition, Increase in adoption of Molecular Imaging for newer applications, and emerging economies such as China, India and others, will create new opportunities for molecular imaging market. However, higher cost of the research and development, and continuous improvement and innovation in molecular imaging technologies are the key restraints for molecular imaging market.

Geographically USA dominated global Molecular Imaging market, and is projected to have fastest growth, owing to high prevalence of the disorder, technological advancements and high awareness among the patient population. Europe was observed to be the second largest market and one of the leading research destinations for neurological disease diagnosis and treatment. Asia-Pacific and Rest of the World were observed to be the most potential markets for Molecular Imaging diagnosis and treatment market.

This report identifies the Molecular Imaging market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to Global molecular Imaging market.

This report segments global Molecular Imaging market on the basis of techniques and regional market as follows:
Molecular Imaging Market By Application: PET, SPECT, MRI, CT, Ultra Sound, & Others
This report has been further segmented into major regions, which include detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region. The major countries considered under the Asia-Pacific region are India, China, South Korea and Japan. The major countries considered under the European region are Germany, U.K., France, Italy, Spain and Russia. The major countries considered under the North American region are United States, Canada and Mexico
This report identifies all the major companies operating in the global Molecular Imaging market. Some of the major companies’ profiles in detail are as follows:
Philips
Siemens
GE Healthcare Affibody
Cyclopharma
Perkin-Elmer
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Molecular Imaging – Market Overview

2. Executive Summary

3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis

4. Molecular Imaging – Market Forces
4.1. Drivers
4.1.1. Aging Population.
4.1.2. The adoption and advancement in technologies such as PET/CT
4.1.3. Non-ionizing imaging techniques
4.1.4. Growing demand for efficient and accurate imaging system
4.2. Restraints
4.2.1 Continuous improvement and innovation in molecular imaging technologies
4.3. Opportunities
4.3.1 Emerging economies
4.3.2 Increase in adoption of Molecular Imaging for newer applications
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Molecular Imaging – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Molecular Imaging Market, By Techniques
6.1. PET
6.2. SPECT
6.3. MRI
6.4. CT
6.5. Ultra Sound
6.6. Others

7. Molecular Imaging Market, By Geography
7.1. Europe
7.1.1. Germany
7.1.2. France
7.1.3. Italy
7.1.4. Spain
7.1.5. Russia
7.1.6. U.K.
7.1.7. Rest of Europe
7.2. Asia Pacific
7.2.1. China
7.2.2. India
7.2.3. Japan
7.2.4. South Korea
7.2.5. Rest of Asia-Pacific
7.3. North America
7.3.1. U.S.
7.3.2. Canada
7.3.3. Mexico
7.4. Rest of the World (RoW)
7.4.1. Brazil
7.4.2. Rest of RoW

8. Molecular Imaging – Market Entropy
8.1. Expansion
8.2. Technological Developments
8.3. Merger & Acquisitions, and Joint Ventures
8.4. Supply- Contract

9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
9.1. Philips
9.2. Siemens
9.3. GE Healthcare
9.4. Cyclopharma
9.5. Perkin-Elmer
9.6. Hamamatsu Photonics
9.7. Scintomics
9.8. Naviscan
9.9. Kereos
9.10. Affibody
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

10. Appendix
10.1. Abbreviations
10.2. Sources
10.3. Research Methodology
10.4. Bibliography
10.5. Compilation of expert Insights
10.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll